Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MYE | Common Stock | Options Exercise | $0 | +1.64K | +11.58% | $0.00 | 15.8K | Mar 6, 2023 | Direct | F1 |
transaction | MYE | Common Stock | Tax liability | -$16.6K | -800 | -5.05% | $20.71 | 15K | Mar 6, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MYE | Restricted Stock Units | Options Exercise | $0 | -1.64K | -100% | $0.00* | 0 | Mar 6, 2023 | Common Stock | 1.64K | Direct | F2, F3 | |
transaction | MYE | Restricted Stock Units | Award | $0 | +3.05K | $0.00 | 3.05K | Mar 6, 2023 | Common Stock | 3.05K | Direct | F2, F4 | ||
transaction | MYE | Restricted Stock Units | Award | $0 | +3.19K | $0.00 | 3.19K | Mar 6, 2023 | Common Stock | 3.19K | Direct | F2, F5 | ||
transaction | MYE | Performance Stock Units | Award | $0 | +4.58K | $0.00 | 4.58K | Mar 6, 2023 | Common Stock | 4.58K | Direct | F6 |
Id | Content |
---|---|
F1 | Restricted stock units convert into common stock on a one-for-one basis. |
F2 | Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock |
F3 | On April 28, 2020, the reporting person was granted 4,932 restricted stock units, vesting in equal annual installments on March 6, 2021, March 6, 2022, and March 6, 2023. |
F4 | On March 6, 2023, the reporting person was granted 3,052 restricted stock units, vesting in three equal annual installments on March 16, 2024, March 16, 2025, and March 16, 2026. |
F5 | On March 6, 2023, the reporting person was granted 3,187 restricted stock units, vesting in three equal annual installments on March 16, 2024, March 16, 2025, and March 16, 2026. |
F6 | Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2025. |